Abstract
Cardiovascular diseases are the main cause of death in diabetic patients. Besides the classic atherogenic and atherothrombotic risk factors, other specific factors of diabetes should be added as endothelial dysfunction, alteration of hemostatic processes and diabetic dyslipidemia. Laboratory results indicate the existence of a hypercoagulable state with increase of the platelet function, alteration of the plasmatic coagulation and decreases in natural inhibitors. This situation facilitates the appearance of thrombosis, underlying the importance of the preventive antithrombotic therapy in these patients. The indication of anticoagulant therapy should be individualized for every patient according to the etiopathogenesis of the absolute thromboembolic risk and/or of the interventional procedure to be performed, if it is necessary.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
